There is no greater threat to health today than cancer, and this year a study from Germany may give hope.

The founder of German biotech company BioNTech said in an interview that a vaccine for cancer could be available by 2030.

BioNTech, Europe's largest biotech unicorn, has developed and produced the mRNA New Crown vaccine in collaboration with Pfizer in the United States.

The company's co-founders, husband, and wife Uğur Şahin and Özlem Türeci, reportedly said in an interview with the BBC that research has made a breakthrough that makes them optimistic that a cancer vaccine will be available in the next few years. Asked when mRNA-based cancer vaccines would be available for patients, Sahin said they could be on the market "by 2030.

BioNTech reportedly has several cancer vaccines in clinical trials right now. BioNTech hopes to develop treatments for bowel cancer, melanoma, and other cancer types, but is still facing major hurdles, Turelli said. This is because the cancer cells that make up a tumor can contain many different proteins, making it extremely difficult to create a vaccine that targets all cancer cells but not healthy tissue.

It is believed that with further research and development, cancer vaccines will be successful in benefiting cancer patients! As there are few people who lose their lives to cancer every year, we as ordinary people must also take active measures to prevent cancer before it happens.